EUS-guided radiofrequency ablation plus chemotherapy versus chemotherapy alone for pancreatic cancer (ERAP): An observational open-label pilot study

BACKGROUND: No study has compared EUS-guided radiofrequency ablation (EUS-RFA) plus systemic chemotherapy (CMT) with CMT alone for unresectable pancreatic ductal adenocarcinoma. METHODS: This study compared the results of treatment in patients receiving EUS-RFA plus concomitant CMT (group A; n = 14)...

Descripción completa

Detalles Bibliográficos
Autores principales: Kongkam, Pradermchai, Tiankanon, Kasenee, Seo, Dong Wan, Luangsukrerk, Thanawat, Sriuranpong, Virote, Nantavithya, Chonnipa, Jantarattana, Trirat, Cañones, Arlyn, Kerr, Stephen J., Tantitanawat, Kittithat, Angsuwatcharakon, Phonthep, Ridtitid, Wiriyaporn, Kullavanijaya, Pinit, Rerknimitr, Rungsun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631592/
https://www.ncbi.nlm.nih.gov/pubmed/37969163
http://dx.doi.org/10.1097/eus.0000000000000003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631592/
https://www.ncbi.nlm.nih.gov/pubmed/37969163
http://dx.doi.org/10.1097/eus.0000000000000003

Ejemplares similares